Skip to main content
. 2024 Jun 27;14(6):e083635. doi: 10.1136/bmjopen-2023-083635

Figure 4. Participant timeline. FEP, cefepime; MEM, meropenem; PIP, piperacillin; PK, pharmacokinetic; SOC, standard of care; TDM, therapeutic drug monitoring.

Figure 4